𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin’s Lymphoma: Japan Clinical Oncology Group Study 9002

✍ Scribed by Tomohiro Kinoshita; Tomomitsu Hotta; Kensei Tobinai; Tohru Kobayashi; Naoki Ishizuka; Masao Tomonaga; Toshiaki Sai; Youichiro Ohno; Masaharu Kasai; Michinori Ogura; Chikara Mikuni; Hironobu Toki; Masayuki Sano; Yasufumi Masaki; Tomoko Ohtsu; Yoshihiro Matsuno; Takeaki Takenaka; Shigeru Shirakawa; Masanori Shimoyama; Lymphoma Study Group of the Japan Clinical Oncology Group (JCOG-LSG)


Book ID
111835370
Publisher
Carden Jennings Publishing
Year
2004
Tongue
English
Weight
253 KB
Volume
80
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.